Kirk Malloy

NanoString Technologies has appointed Kirk Malloy to its Board of Directors. Malloy brings 20 years of experience in the life science tools, applied markets, and molecular diagnostics markets. He is the founder of consulting firm BioAdvisors, and was previously senior VP and general manager of life sciences and applied markets at Illumina. Prior to that, Malloy worked at Biosite and Qiagen. He also sits on the boards of publicly traded Organovo Holdings and the privately-held firms Edico Genome, iGenomx, and Agilome.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.